Advertisement
Home Blog Page 2344
The incidence of myocardial infarction is higher in men than women

Several Risk Factors More Strongly Linked to MI in Women

0
Blood pressure, smoking, type 1 and 2 diabetes linked to higher hazard ratios for women than men
The interpretation of genomic epilepsy tests has evolved rapidly in the last five years

Results of Pediatric Genomic Epilepsy Tests Often Reclassified

0
Over 30 percent of pediatric patients with genetic dx, undiagnosed conditions had results reclassified
Xospata (gilteritinib) tablets were approved today by the U.S. Food and Drug Administration for treatment of relapsed or refractory acute myeloid leukemia (AML) in adults with an FLT3 mutation

FDA Approves Treatment for AML Patients With Gene Mutation

0
Expanded approval also granted to mutation assay used to detect FLT3 mutation in AML patients
Firdapse (amifampridine) tablets have been approved by the U.S. Food and Drug Administration for adults with Lambert-Eaton myasthenic syndrome.

FDA Approves Firdapse for Rare Autoimmune Disorder

0
First agency-sanctioned treatment for adults with Lambert-Eaton myasthenic syndrome
Risk for heat-related disease and death is rising worldwide due to climate change

Climate Change Ups Heat Deaths, Especially Among Elderly

0
More people vulnerable to heat exposure, potentially causing heat stress, heart and kidney disease
Most proposed bills in state legislatures from 2011 to 2017 sought to expand access to immunization exemptions

Most Bills Enacted Into Law Limit Vaccine Exemptions

0
However, more than half of proposed bills sought to expand access to immunization exemptions
Being overweight likely plays a causal role in the development of depression

Genetic Analysis Shows Higher BMI May Up Risk for Depression

0
Findings based on large study assessing genetic causal link, even without metabolic effects
When using brief cognitive assessments

Dementia Often Misclassified With Brief Cognitive Assessments

0
Only consistent predictor of overall misclassification was absence of informant-rated poor memory
From 2016 to 2017

CDC: U.S. Life Expectancy Decreased From 2016 to 2017

0
Reports also show recent increases in drug overdose deaths and suicide mortality in United States
Certain sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists demonstrate significant cardiovascular (CV) benefit and should be used for reducing CV risk in patients with type 2 diabetes and atherosclerotic cardiovascular disease

Certain SGLT2 Inhibitors, GLP-1 RAs for T2DM Also Cut CV Risk

0
Report provides guidance on reducing CV risk in patients with T2DM and atherosclerotic CV disease